CompletedN/Aketamine

Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain

Sponsored by Defense and Veterans Center for Integrative Pain Management

NCT ID
NCT04057989
Target Enrollment
80 participants
Start Date
2014-08
Est. Completion
2017-08-30

About This Study

Using a retrospective review of records, we will conduct a multivariate analysis to examine the relationship between exposure to ketamine, as an analgesic agent in combat related trauma care, the use of additional opioid pain medications, and patient reported pain levels.

Conditions Studied

Pain, AcuteAnalgesiaAmputation, TraumaticPost Traumatic Stress DisorderTrauma, Brain

Interventions

  • ketamine

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Battlefield injured from January 2007 to December 2013
* Prescribed a ketamine infusion for acute pain
* Awake, alert (non intubated/sedated), and able to report pain scores 24 hours prior to the start of infusion and up to 48 hours following infusion

Exclusion Criteria:

* Patients who did not receive an injury in theater and did not receive ketamine while being treated by the APS or WRNMMC/WRAMC hospital staff
* No continuous perineural catheter or epidural placement while on ketamine infusion
* Less than 18 years old

Study Locations (1)

Walter Reed National Military Medical Center
Bethesda, Maryland, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain | Huxley